Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growth

BACKGROUND: Bosutinib is a third-generation dual tyrosine kinase inhibitor (TKI) inhibiting Abl and Src kinases. It was developed to act on up-regulated tyrosine kinases (TKs) like BCR-ABL in Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) when resistance to first- and second-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauer, Josephine Tabea, Hofbauer, Lorenz C., Jung, Roland, Erben, Reinhold G., Suttorp, Meinolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
Animal Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852366/
https://www.ncbi.nlm.nih.gov/pubmed/24185529
http://dx.doi.org/10.12659/MSMBR.889518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852366/
https://www.ncbi.nlm.nih.gov/pubmed/24185529
http://dx.doi.org/10.12659/MSMBR.889518

Ejemplares similares